Arizona Administrative Code
Title 9 - HEALTH SERVICES
Chapter 6 - DEPARTMENT OF HEALTH SERVICE - COMMUNICABLE DISEASES AND INFESTATIONS
Article 3 - CONTROL MEASURES FOR COMMUNICABLE DISEASES AND INFESTATIONS
- Section R9-6-301 - Definitions
- Section R9-6-302 - Local Health Agency Control Measures
- Section R9-6-303 - Isolation, Quarantine, Exclusion, and Other Control Measures
- Section R9-6-304 - Food Establishment Control Measures
- Section R9-6-305 - Control Measures for Multi-drug-resistant Organisms
- Section R9-6-306 - Amebiasis
- Section R9-6-307 - Anaplasmosis
- Section R9-6-308 - Anthrax
- Section R9-6-309 - Arboviral Infection
- Section R9-6-310 - Babesiosis
- Section R9-6-311 - Basidiobolomycosis
- Section R9-6-312 - Botulism
- Section R9-6-313 - Brucellosis
- Section R9-6-314 - Campylobacteriosis
- Section R9-6-315 - Carbapenem-resistant Enterobacteriaceae
- Section R9-6-316 - Chagas Infection and Related Disease (American Trypanosomiasis)
- Section R9-6-317 - Chancroid (Haemophilus ducreyi)
- Section R9-6-318 - Chikungunya
- Section R9-6-319 - Chlamydia trachomatis Infection
- Section R9-6-320 - Cholera
- Section R9-6-321 - Clostridium difficile
- Section R9-6-322 - Coccidioidomycosis (Valley Fever)
- Section R9-6-323 - Colorado Tick Fever
- Section R9-6-324 - Conjunctivitis: Acute
- Section R9-6-325 - Creutzfeldt-Jakob Disease
- Section R9-6-326 - Cryptosporidiosis
- Section R9-6-327 - Cyclospora Infection
- Section R9-6-328 - Cysticercosis
- Section R9-6-329 - Dengue
- Section R9-6-330 - Diarrhea, Nausea, or Vomiting
- Section R9-6-331 - Diphtheria
- Section R9-6-332 - Ehrlichiosis
- Section R9-6-333 - Emerging or Exotic Disease
- Section R9-6-334 - Encephalitis, Viral or Parasitic
- Section R9-6-335 - Escherichia coli, Shiga Toxin-producing
- Section R9-6-336 - Giardiasis
- Section R9-6-337 - Glanders
- Section R9-6-338 - Gonorrhea
- Section R9-6-339 - Haemophilus influenzae: Invasive Disease
- Section R9-6-340 - Hansen's Disease (Leprosy)
- Section R9-6-341 - Hantavirus Infection
- Section R9-6-342 - Hemolytic Uremic Syndrome
- Section R9-6-343 - Hepatitis A
- Section R9-6-344 - Hepatitis B and Hepatitis D
- Section R9-6-345 - Hepatitis C
- Section R9-6-346 - Hepatitis E
- Section R9-6-347 - HIV Infection and Related Disease
- Section R9-6-348 - Influenza-Associated Mortality in a Child
- Section R9-6-349 - Legionellosis (Legionnaires' Disease)
- Section R9-6-350 - Leptospirosis
- Section R9-6-351 - Listeriosis
- Section R9-6-352 - Lyme Disease
- Section R9-6-353 - Lymphocytic Choriomeningitis
- Section R9-6-354 - Malaria
- Section R9-6-355 - Measles (Rubeola)
- Section R9-6-356 - Melioidosis
- Section R9-6-357 - Meningococcal Invasive Disease
- Section R9-6-358 - Methicillin-resistant Staphylococcus aureus (MRSA)
- Section R9-6-359 - Mumps
- Section R9-6-360 - Norovirus
- Section R9-6-361 - Novel Coronavirus (e.g., SARS or MERS)
- Section R9-6-362 - Pediculosis (Lice Infestation)
- Section R9-6-363 - Pertussis (Whooping Cough)
- Section R9-6-364 - Plague
- Section R9-6-365 - Poliomyelitis (Paralytic or Non-paralytic)
- Section R9-6-366 - Psittacosis (Ornithosis)
- Section R9-6-367 - Q Fever
- Section R9-6-368 - Rabies in a Human
- Section R9-6-369 - Relapsing Fever (Borreliosis)
- Section R9-6-370 - Respiratory Disease in a Health Care Institution or Correctional Facility
- Section R9-6-371 - Rubella (German Measles)
- Section R9-6-372 - Rubella Syndrome, Congenital
- Section R9-6-373 - Salmonellosis
- Section R9-6-374 - Scabies
- Section R9-6-375 - Shigellosis
- Section R9-6-376 - Smallpox
- Section R9-6-377 - Spotted Fever Rickettsiosis (e.g., Rocky Mountain Spotted Fever)
- Section R9-6-378 - Streptococcal Group A Infection
- Section R9-6-379 - Streptococcal Group B Invasive Infection in an Infant Younger Than 90 Days of Age
- Section R9-6-380 - Streptococcus pneumoniae Invasive Infection
- Section R9-6-381 - Syphilis
- Section R9-6-382 - Taeniasis
- Section R9-6-383 - Tetanus
- Section R9-6-384 - Toxic Shock Syndrome
- Section R9-6-385 - Trichinosis
- Section R9-6-386 - Tuberculosis
- Section R9-6-387 - Tularemia
- Section R9-6-388 - Typhoid Fever
- Section R9-6-389 - Typhus Fever
- Section R9-6-390 - Vaccinia-related Adverse Event
- Section R9-6-391 - Vancomycin-Resistant or Vancomycin-Intermediate Staphylococcus aureus
- Section R9-6-392 - Varicella (Chickenpox)
- Section R9-6-393 - Vibrio Infection
- Section R9-6-394 - Viral Hemorrhagic Fever
- Section R9-6-395 - West Nile Virus Infection
- Section R9-6-396 - Yellow Fever
- Section R9-6-397 - Yersiniosis (Enteropathogenic Yersinia)
- Section R9-6-398 - Zika Virus Infection
- Exhibit III-A
- Exhibit III-B
- Exhibit III-C
- Exhibit III-D
- Exhibit III-E
- Exhibit III-F
- Exhibit III-G
- Exhibit III-H
- Exhibit III-I
- Exhibit III-J
- Exhibit III-K
- Exhibit III-L
- Exhibit III-M
- Exhibit III-N
Disclaimer: These regulations may not be the most recent version. Arizona may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
